Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Aurigene Discovery Technologies Limited patents


Recent patent applications related to Aurigene Discovery Technologies Limited. Aurigene Discovery Technologies Limited is listed as an Agent/Assignee. Note: Aurigene Discovery Technologies Limited may have other listings under different names/spellings. We're not affiliated with Aurigene Discovery Technologies Limited, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Aurigene Discovery Technologies Limited-related inventors


Substituted aza compounds as irak-4 inhibitors

The present invention provides substituted aza compounds of formula (i) or (ii) and pharmaceutically acceptable salts thereof, and their use to inhibit irak-4 and/or for the treatment of diseases or disorders induced by irak-4.. . ... Aurigene Discovery Technologies Limited

Indazole and azaindazole compounds as irak-4 inhibitors

The present invention provides indazole and aza indazole compounds of formula (i) or (ii) and pharmaceutically acceptable salts thereof, and their use to inhibit irak-4 and/or for the treatment of diseases or disorders induced by irak-4.. . ... Aurigene Discovery Technologies Limited

Substituted tetrahydroquinolinone compounds as ror gamma modulators

The present invention provides substituted tetrahydroquinolinone and related compounds of formula (i), which are therapeutically useful as modulators of retinoic acid receptor-related orphan receptors (rors), more particularly as rorγ modulators. These compounds are useful in the treatment and prevention of diseases and/or disorder, in particular their use in diseases and/or disorder mediated by rorγ receptor. ... Aurigene Discovery Technologies Limited

Substituted heterocyclyl derivatives as cdk inhibitors

The present invention provides substituted heterocyclyl derivatives of formula (i), which are therapeutically useful, particularly as selective transcriptional cdk inhibitors including cdk7, cdk9, cdk12, cdk13 and cdk18, more particularly transcriptional cdk7 inhibitors. These compounds are useful in the treatment and prevention of diseases and/or disorders associated with selective transcriptional cdks in a mammal. ... Aurigene Discovery Technologies Limited

3-substituted-1,2,4-oxadiazole and thiadiazole compounds as immunomodulators

. . . . . . The present invention relates to 3-substituted-1,2,4-oxadiazole and thiadiazole compounds of formula (i) or formula (ii) and their use to inhibit the programmed cell death 1 (pd-1) signaling pathway and/or for treatment of disorders by inhibiting an immunosuppressive signal induced by pd-1, pd-l1 or pd-l2.. . ... Aurigene Discovery Technologies Limited

3-substituted 1,3,4-oxadiazole and thiadiazole compounds as immunomodulators

The present invention relates to 3-substituted 1,3,4-oxadiazole and thiadiazole compounds of formula (i) and their use to inhibit the programmed cell death 1 (pd-1) signaling pathway and/or for treatment of disorders by inhibiting an immunosuppressive signal induced by pd-1, pd-l1 or pd-l2.. . ... Aurigene Discovery Technologies Limited

1,3,4-oxadiazole and thiadiazole compounds as immunomodulators

The present invention relates to 1,3,4-oxadiazole and thiadiazole compounds of formula (i) and their use to inhibit the programmed cell death 1 (pd-1) signaling pathway and/or for treatment of disorders by inhibiting an immunosuppressive signal induced by pd-1, pd-l1 or pd-l2.. . ... Aurigene Discovery Technologies Limited

4,5-dihydroisoxazole derivatives as nampt inhibitors

. . . . . . The present invention provides 4,5-dihydroisoxazole derivatives of formula (i), which may be therapeutically useful, more particularly as nampt inhibitors. Wherein, ring a, l1, l2, x1, x2, x3, z, r1, r2, r3, r4, r5, m, n, p and q have the meanings given in the specification and pharmaceutically acceptable salts thereof that are useful in the treatment and prevention of diseases or disorder, caused by an elevated level of nicotinamide phosphoribosyltransferase (nampt) in a mammal. ... Aurigene Discovery Technologies Limited

Substituted indazole compounds as irak4 inhibitors

The present invention provides substituted indazole compound of formula (i) and pharmaceutically acceptable salts thereof, and their use to inhibit irak4 and/or for the treatment of diseases or disorders induced by irak4.. . ... Aurigene Discovery Technologies Limited

Cyclic peptidomimetic compounds as immunomodulators

The present invention relates to cyclic peptidomimetic compounds as therapeutic agents capable of inhibiting the programmed cell death 1 (pd1) signalling pathway. The invention also relates to derivatives of the therapeutic agents. ... Aurigene Discovery Technologies Limited

1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulators

The present invention relates to 1,3,4-oxadiazole and 1,3,4-thiadiazole compounds as therapeutic agents capable of inhibiting the programmed cell death 1 (pd1) signalling pathway. The invention also refers to derivatives of the therapeutic agents. ... Aurigene Discovery Technologies Limited

1,2,4-oxadiazole derivatives as immunomodulators

The present invention relates to 1,2,4-oxadiazole and 1,2,4-thiadiazole compounds as therapeutic agents capable of inhibiting the programmed cell death 1 (pd1) signaling pathway. The invention also refers to derivatives of the therapeutic agents. ... Aurigene Discovery Technologies Limited

Crystalline structure of fabi from burkholderia pseudomallei

The present invention relates to drug targets for burkholderia pseudomallei. The invention provides a crystalline polypeptide derived from burkholderia pseudomallei comprising the amino acid sequence set forth in seq id no: 1. ... Aurigene Discovery Technologies Limited








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Aurigene Discovery Technologies Limited in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Aurigene Discovery Technologies Limited with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###